Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.41
+0.05 (0.93%)
Feb 20, 2026, 4:00 PM EST - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $343.55 million as of February 23, 2026. Its market cap has decreased by -16.23% in one year.
Market Cap
343.55M
Enterprise Value
199.44M
1-Year Change
-16.23%
Ranking
Category
Stock Price
$5.41
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $343.55M, a decrease of -13.62%. That is a compound annual growth rate of -3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 343.55M | -0.73% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Benitec Biopharma | 364.47M |
| Atea Pharmaceuticals | 363.29M |
| LENZ Therapeutics | 362.65M |
| Nautilus Biotechnology | 356.18M |
| Aclaris Therapeutics | 351.04M |
| Puma Biotechnology | 344.17M |
| Rezolute | 341.74M |
| Cybin | 340.74M |